Ava Davis
Amid the persistent global challenges posed by the SARS-CoV-2 pandemic, the utilization of rapid antigen tests has significantly enhanced diagnostic capabilities. However, their applicability extends beyond mere diagnosis, offering a promising avenue for whole virus sequencing and variant detection. This article explores the potential and limitations of positive SARS-CoV-2 rapid antigen tests in RNA-based genomic surveillance. By discussing methodologies, challenges, and implications, this research underscores the pivotal role of these tests in preserving comprehensive genomic surveillance amid evolving viral variants.
इस लेख का हिस्सा